|
Market Closed -
Bombay S.E.
06:20:11 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 2,144.70 INR | +2.52% |
|
+2.32% | +1.55% |
| 09-04 | Lupin Limited Receives U.S. FDA Approval For Modafinil Tablets USP 100 Mg And 200 Mg | CI |
| 08-28 | Lupin Assigned ESG rating by Crisil ESG Ratings & Analytics | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LUPIN LIMITED | Other Pharmaceuticals | +2.52% | +2.32% | +1.55% | +4.30% | +125.59% | 10.22B |  | |  |
- Stock Market
- Stocks
- LUPIN Stock
- Charts Lupin Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
